• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于价值的认知行为疗法治疗初级保健中抑郁症的定价:一项经济评估。

Value-based pricing of cognitive behavioral therapy for depression in primary care: an economic evaluation.

机构信息

Frankfurt School of Finance & Management, Adickesallee 32-34, Frankfurt am Main, 60322, Germany.

出版信息

BMC Health Serv Res. 2024 Mar 8;24(1):317. doi: 10.1186/s12913-024-10653-5.

DOI:10.1186/s12913-024-10653-5
PMID:38459545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10924317/
Abstract

OBJECTIVES

Value-based pricing (VBP) determines product prices based on their perceived benefits. In healthcare, VBP prices medical technologies considering health outcomes and other relevant factors. This study applies VBP using economic evaluation to provider-patient communication, taking cognitive behavioral therapy (CBT) for adult primary care patients with depressive disorders as a case study.

METHODS

A 12-week decision-tree model was developed from the German social health insurance system's perspective, comparing CBT against the standard of care. The influence of an extended time horizon on VBP was assessed using a theoretical model and long-term data spanning 46 months.

RESULTS

Using a willingness-to-pay threshold of €88,000 per quality-adjusted life year gained, the base-case 50-minute compensation rate for CBT was €45. Assuming long-term effects of CBT significantly affected the value-based compensation, increasing it to €226.

CONCLUSIONS

This study showcases the potential of applying VBP to CBT. However, significant price variability is highlighted, contingent upon assumptions regarding CBT's long-term impacts.

摘要

目的

基于价值的定价(VBP)根据产品的感知收益来确定价格。在医疗保健领域,VBP 根据健康结果和其他相关因素来为医疗技术定价。本研究通过经济评估将 VBP 应用于医患沟通中,以认知行为疗法(CBT)治疗成年初级保健患者的抑郁障碍为例。

方法

从德国社会健康保险制度的角度出发,开发了一个为期 12 周的决策树模型,将 CBT 与标准护理进行比较。使用理论模型和跨越 46 个月的长期数据评估了延长时间范围对 VBP 的影响。

结果

使用每获得一个质量调整生命年的意愿支付阈值为 88000 欧元,基础案例中 CBT 的 50 分钟补偿率为 45 欧元。假设 CBT 的长期效果对基于价值的补偿有重大影响,将其提高到 226 欧元。

结论

本研究展示了将 VBP 应用于 CBT 的潜力。然而,强调了显著的价格可变性,取决于对 CBT 的长期影响的假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e5/10924317/f92a88005192/12913_2024_10653_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e5/10924317/9e428f3a3035/12913_2024_10653_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e5/10924317/6c6cfc3e1d6a/12913_2024_10653_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e5/10924317/f92a88005192/12913_2024_10653_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e5/10924317/9e428f3a3035/12913_2024_10653_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e5/10924317/6c6cfc3e1d6a/12913_2024_10653_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e5/10924317/f92a88005192/12913_2024_10653_Fig3_HTML.jpg

相似文献

1
Value-based pricing of cognitive behavioral therapy for depression in primary care: an economic evaluation.基于价值的认知行为疗法治疗初级保健中抑郁症的定价:一项经济评估。
BMC Health Serv Res. 2024 Mar 8;24(1):317. doi: 10.1186/s12913-024-10653-5.
2
Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.互联网提供的针对重度抑郁症和焦虑症的认知行为疗法:一项卫生技术评估。
Ont Health Technol Assess Ser. 2019 Feb 19;19(6):1-199. eCollection 2019.
3
Economic Evaluation of Cognitive Behavioral Therapy for Depression: A Systematic Review.经济评估抑郁症认知行为疗法:系统评价。
Value Health. 2022 Jun;25(6):1030-1041. doi: 10.1016/j.jval.2021.11.1379. Epub 2022 Apr 11.
4
Comparative value-based pricing of an Ebola vaccine in resource-constrained countries based on cost-effectiveness analysis.基于成本效益分析的资源有限国家埃博拉疫苗的比较价值定价。
J Med Econ. 2022 Jan-Dec;25(1):894-902. doi: 10.1080/13696998.2022.2091858.
5
Cost-effectiveness of a randomized trial to treat depression among Latinos.一项治疗拉丁裔抑郁症随机试验的成本效益分析
J Ment Health Policy Econ. 2014 Jun;17(2):41-50.
6
Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.认知行为疗法作为辅助药物治疗用于基层医疗中难治性抑郁症的临床疗效和成本效益:CoBalT随机对照试验
Health Technol Assess. 2014 May;18(31):1-167, vii-viii. doi: 10.3310/hta18310.
7
Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.行为激活(COBRA)的成本和结果:行为激活与认知行为疗法治疗抑郁症的随机对照试验。
Health Technol Assess. 2017 Aug;21(46):1-366. doi: 10.3310/hta21460.
8
Cost-effectiveness of In-Home Cognitive Behavioral Therapy for low-income depressed mothers participating in early childhood prevention programs.针对参与幼儿预防项目的低收入抑郁母亲的居家认知行为疗法的成本效益
J Affect Disord. 2017 Jan 15;208:475-482. doi: 10.1016/j.jad.2016.10.041. Epub 2016 Nov 3.
9
Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.针对精神病的认知行为疗法:一项卫生技术评估。
Ont Health Technol Assess Ser. 2018 Oct 24;18(5):1-141. eCollection 2018.
10
Cost Effectiveness of Cognitive Behavioral Therapy for the Treatment of Subjective Tinnitus in Australia.认知行为疗法治疗澳大利亚主观性耳鸣的成本效益
Ear Hear. 2022 Mar/Apr;43(2):507-518. doi: 10.1097/AUD.0000000000001112.

本文引用的文献

1
Depressive symptoms among adults in Germany.德国成年人中的抑郁症状。
J Health Monit. 2017 Oct 9;2(3):77-83. doi: 10.17886/RKI-GBE-2017-070. eCollection 2017 Oct.
2
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany.基于模型的德国成本效益阈值估算。
Appl Health Econ Health Policy. 2023 Jul;21(4):627-635. doi: 10.1007/s40258-023-00803-x. Epub 2023 Apr 11.
3
Accuracy Requirements for Cost-effective Suicide Risk Prediction Among Primary Care Patients in the US.美国初级保健患者中具有成本效益的自杀风险预测的准确性要求。
JAMA Psychiatry. 2021 Jun 1;78(6):642-650. doi: 10.1001/jamapsychiatry.2021.0089.
4
Cost-Utility of Internet-Based Cognitive Behavioral Therapy in Unipolar Depression: A Markov Model Simulation.基于互联网的认知行为疗法治疗单相抑郁症的成本-效用:马尔可夫模型模拟。
Appl Health Econ Health Policy. 2020 Aug;18(4):567-578. doi: 10.1007/s40258-019-00551-x.
5
The effects of fifteen evidence-supported therapies for adult depression: A meta-analytic review.十五种成人抑郁症的循证治疗效果:一项荟萃分析综述。
Psychother Res. 2020 Mar;30(3):279-293. doi: 10.1080/10503307.2019.1649732. Epub 2019 Aug 8.
6
New Cost-Effectiveness Methods to Determine Value-Based Prices for Potential Cures: What Are the Options?新的成本效益方法用于确定潜在治愈方法的基于价值的价格:有哪些选择?
Value Health. 2019 Jun;22(6):656-660. doi: 10.1016/j.jval.2019.01.012. Epub 2019 May 17.
7
Cost-utility of screening for depression among asylum seekers: a modelling study in Germany.对寻求庇护者中的抑郁症进行筛查的成本-效用:德国的建模研究。
Health Policy. 2019 Sep;123(9):873-881. doi: 10.1016/j.healthpol.2019.05.011. Epub 2019 May 16.
8
Cognitive behaviour therapy for depression in primary care: systematic review and meta-analysis.认知行为疗法在初级保健中的抑郁治疗:系统评价和荟萃分析。
Psychol Med. 2019 Jun;49(8):1266-1274. doi: 10.1017/S0033291718004208. Epub 2019 Jan 28.
9
Cost-Effectiveness Analysis of Aripiprazole Augmentation Treatment of Patients with Major Depressive Disorder Compared to Olanzapine and Quetiapine Augmentation in Turkey: A Microsimulation Approach.阿立哌唑增效治疗与奥氮平和喹硫平增效治疗相比在土耳其重性抑郁症患者中的成本效益分析:一种微观模拟方法
Value Health Reg Issues. 2013 Sep-Oct;2(2):171-180. doi: 10.1016/j.vhri.2013.06.004. Epub 2013 Aug 3.
10
The Treatment of Depression in Primary Care.基层医疗中的抑郁症治疗。
Dtsch Arztebl Int. 2017 Oct 27;114(43):721-728. doi: 10.3238/arztebl.2017.0721.